Avadel (AVDL) Probability Sentiment 2
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Probability Sentiment SUMMARY In March 2021, the FDA assigned an October [...]
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Probability Sentiment SUMMARY In March 2021, the FDA assigned an October [...]
Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and webcast at 8 am Eastern on July 13, 2020, to [...]
Avadel Pharmaceuticals plc (NASDAQ:AVDL) recently announced positive phase III trial results for its drug FT218 to treat excessive daytime sleepiness [...]
Onconova Coverage suspended, Oragenics falls short in Phase II trial. The FDA last week approved Acceleron Pharma Inc. (NASDAQ:XLRN) luspatercept [...]